Evidence map›Paper›PMID 28915273›Full record

Trial reportPloS one2017

Longitudinal co-variations between inflammatory cytokines, lung function and patient reported outcomes in patients with asthma.

Karin Lodin, Mats Lekander, Jörgen Syk, Kjell Alving, Predrag Petrovic, Anna Andreasson

Erratum issuedOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Karin LodinDepartment of Neurobiology, Care Sciences and Society, Division of Family Medicines and Primary Care, Karolinska Institutet, Huddinge, Sweden.ORCID http://orcid.org/0000-0002-3789-199X
Mats LekanderDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Jörgen SykDepartment of Neurobiology, Care Sciences and Society, Division of Family Medicines and Primary Care, Karolinska Institutet, Huddinge, Sweden.
Kjell AlvingDepartment of Women's and Children's health, Uppsala University, Uppsala, Sweden.
Predrag PetrovicDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Anna AndreassonDepartment of Neurobiology, Care Sciences and Society, Division of Family Medicines and Primary Care, Karolinska Institutet, Huddinge, Sweden.
Karolinska Institutet · SEStockholm University · SEUppsala University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAsthma is a chronic inflammatory respiratory disorder associated with reduced lung function and poor quality of life. The condition is also associated with poor self-rated health, a major predictor of objective health trajectories. Of biological correlates to self-rated health, evidence suggests a role for inflammatory cytokines and related sickness behaviours. However, this is mainly based on cross-sectional data, and the relation has not been investigated in patients with chronic inflammatory conditions.

objectiveTo investigate inflammatory cytokines, lung function, sickness behaviour and asthma-related quality of life as determinants of self-rated health in patients with asthma, and to investigate if these variables co-vary over time.

methodsPlasma cytokines (IL-5, IL-6), lung function (FEV1), sickness behaviour, asthma-related quality of life and self-rated health were assessed in 181 patients with allergic asthma aged 18-64 years in a one-year longitudinal study. Mixed effect regression models and Spearman's correlation were performed to analyse the associations between repeated measurements.

resultsMore sickness behaviour and poorer asthma-related quality of life were associated with poorer self-rated health (p's<0.001). In men, both low and high levels of interleukin (IL)-6 and poorer lung function were related with poorer self-rated health (p's<0.05). Over the year, improved asthma-related quality of life was associated with better self-rated health (Spearman's rho = -0.34 women,-0.36 men, p's<0.01). Further, if sickness behaviour decreased, self-rated health improved, but only in women (Rho = -0.21, p<0.05). Increased FEV1 in men was associated with an increase in IL-6 (Rho = 0.24, p<0.05) as well as improved self-rated health (Rho = -0.21, p<0.05) and asthma-related quality of life (Rho = 0.29, p<0.01) over the year.

conclusionThe study highlights the importance of subjectively perceived sickness behaviour and asthma-related quality of life together with lung function as determinants of self-rated health in asthmatic patients. The importance of inflammatory activation for patient reported outcomes in chronic inflammatory conditions need further investigation.

Indexed as

Quality of LifeAdolescentAdultAsthmaFemaleHumansInterleukin-5Interleukin-6Longitudinal StudiesMaleMiddle AgedRespiratory Function TestsIL5 protein, humanIL6 protein, humanInterleukin-5Interleukin-6

Identifiers

PMID28915273
PMCPMC5600400
OpenAlexW2755929216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.